secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alzamend Neuro, Inc. (ALZN)
CIK:        0001677077
Form:       8-K
Filed at:   2024-07-31T23:59:59+00:00
Accession:  0001214659-24-013382
Event type: regulatory
Sentiment:  neutral
Materiality: 0.45
Item codes: 7.01, 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alzamend Neuro regains Nasdaq bid price compliance; MVLS deficiency still pending
--------------------------------------------------------------------------------

- Nasdaq notified Alzamend on July 30, 2024 that bid price compliance is regained after 10 consecutive days above $1.00.
- Minimum Bid Price Requirement was met on July 29, 2024; matter is now closed.
- MVLS deficiency remains: Alzamend must demonstrate compliance with $2.5M stockholder equity by September 23, 2024.
- Company appealed delisting for MVLS; hearing panel granted extension to Sept 23, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1677077/000121465924013382/0001214659-24-013382-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1677077/000121465924013382/o7302498k.htm
  HTML page:      https://secwatch.observer/filing/0001214659-24-013382

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer